|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.170 -0.005 (-2.857%) | 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 198,032 | -38.753% | 323,334 | 291,415 | 218,805 | 329,979 |
| Cost of Sales | (142,036) | -27.424% | (195,706) | (176,451) | (122,172) | (217,202) |
| Gross Profit | 55,996 | -56.126% | 127,628 | 114,964 | 96,633 | 112,777 |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (166) | -- | -- | -- | -- | (164,702) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | (24,458) | 60,362 | |
| Profit / (Loss) before Taxation | (272,585) | 36.852% | (199,183) | (122,970) | (171,983) | (194,896) | |
| Taxation | 16 | -- | (3,473) | (971) | (6) | (4,213) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 3,630 | -20.932% | 4,591 | 50,993 | 3,213 | (1,404) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (268,939) | 35.783% | (198,065) | (72,948) | (168,776) | (200,513) | |
| 2023/12 - Final HKD(K$) | %Chg (Compare to Final) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | 7,292 | -66.167% | 21,553 | 16,970 | 31,703 | 16,338 |
| Depreciation & Amortisation | 36,585 | 10.402% | 33,138 | 22,700 | 28,449 | 31,582 |
| Directors' Emoluments | 7,022 | -6.035% | 7,473 | 7,195 | 4,751 | 6,469 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Disclaimer | -- | Unqualified (Modified Report) | Disclaimer | Unqualified | Unqualified (Modified Report) |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -9.580 | 35.694% | -7.060 | -2.610 | -6.320 | -8.190 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.001 | -- | (0.009) | (0.019) | (0.006) | (0.084) |
| NBV per share ($) | 0.000 | -- | 0.094 | 0.167 | 0.176 | 0.221 |
| Remarks: | Real time quote last updated: 22/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -47,969,000 |
| %Change | -42.861% |
| EPS / (LPS) | HKD -0.017 |
| NBV Per Share ($) | HKD -0.017 |